These mitochondrial effects block both cell proliferation and differentiation [7]
Not for human or veterinary, diagnostic, or therapeutic use
Liepinsh E, Kuka J, Vilks K, Svalbe B, Stelfa G, Vilskersts R, et al
Newer medications in development, including retatrutide (a triple GIP/GLP-1/glucagon agonist) and amycretin, show promise for improving the fat-to-lean mass ratio during weight loss
In mesothelioma models, SFN disrupts PRMT5/MEP50 complex function, inhibiting its methyltransferase activity, reactivating tumor suppressor expression, and suppressing cancer cell proliferation, invasion, and stem-like properties (79, 80)
Low omega-3 index and polyunsaturated fatty acid status in patients with chronic fatigue syndrome/myalgic encephalomyelitis